AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUMOS DIAGNOSTICS HOLDINGS L

0.065

-0.005-7.14%

Volume:21.16M

Turnover:1.43M

Market Cap:48.65M

PE:-4.64

High:0.073

Open:0.070

Low:0.063

Close:0.070

Loading ...

Overview Company News Filings

BUZZ-Australia's Lumos Diagnostics gains on advancing respiratory test sales

Several Insiders Invested In Lumos Diagnostics Holdings Flagging Positive News

Simply Wall St.

BUZZ-Australia's Lumos Diagnostics hits two-month high on upbeat Q3 results

BRIEF-Lumos Diagnostics Reports Revenue Of Us$3.5 Million For Quarter

Lumos Diagnostics Holdings Ltd - Revenue of US$3.5 Mln for Quarter

THOMSON REUTERS

Lumos Diagnostics Holdings Expands US Medicare Reimbursement Coverage for Diagnostic Test, Shares Jump 4%

MT Newswires Live

Lumos Diagnostics to Receive Medicare Reimbursement for Test in Two US Regions; Shares Rise 14%

MT Newswires Live

Lacklustre Performance Is Driving Lumos Diagnostics Holdings Limited's (ASX:LDX) 29% Price Drop

Simply Wall St.

Lumos Diagnostics Holdings Agrees to Expand Scope of Work for Women's Health Test

MT Newswires Live

BRIEF-Lumos Diagnostics Posts HY Loss Attributable $2.8 Mln

Lumos Diagnostics - Hy Loss Attributable $2.8 Mln

THOMSON REUTERS

BRIEF-Lumos Diagnostics Logs Unaudited Revenue $2.9 Mln For Qtr

Lumos Diagnostics - Unaudited Revenue of US$2.9 Mln for Quarter

THOMSON REUTERS

Lumos Diagnostics Holdings Limited's (ASX:LDX) Share Price Boosted 31% But Its Business Prospects Need A Lift Too

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LDX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.065,"timestamp":1752819120000,"preClose":0.07,"halted":0,"volume":21164086,"delay":0,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":748523022,"eps":-0.014005597935434686,"marketStatus":"Market Closed","change":-0.005,"latestTime":"07-18 16:12:00 AEST","open":0.07,"high":0.073,"low":0.063,"amount":1429785,"amplitude":0.142857,"askPrice":0.067,"askSize":481546,"bidPrice":0.065,"bidSize":47401,"shortable":3,"etf":0,"ttmEps":-0.014005597935434686,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.07,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":1.0693955241538537,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-13.86%","roe":"-52.41%","lyrEps":-0.028511,"volumeRatio":1.0693955241538537,"shares":748523022,"dividePrice":0,"high":0.073,"amplitude":0.142857,"preClose":0.07,"low":0.063,"week52Low":0.019,"pbRate":"3.23","psRate":"2.16","week52High":0.08,"institutionHeld":0,"latestPrice":0.065,"committee":-0.820772,"eps":-0.014005597935434686,"divideRate":0,"volume":21164086,"delay":0,"ttmEps":-0.014005597935434686,"open":0.07,"prevYearClose":0.035,"prevWeekClose":0.029,"prevMonthClose":0.027,"prevQuarterClose":0.027,"fiveDayClose":0.029,"twentyDayClose":0.029,"sixtyDayClose":0.026},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535527400","title":"BUZZ-Australia's Lumos Diagnostics gains on advancing respiratory test sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2535527400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535527400?lang=en_us&edition=fundamental","pubTime":"2025-05-14 10:31","pubTimestamp":1747189887,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Lumos Diagnostics gains on advancing respiratory test sales** Lumos Diagnostics LDX.AX rises 3.9% to A$0.027; marks biggest intraday percentage gain since May 7** Medical equipment supplier says it received and shipped $126,000 purchase order for FebriDx from iMedical, Inc.** Adds order largest single purchase order since the test's launch; signals rise in U.S. customer adoption and continued market acceptance of FebriDx** FebriDx is a rapid point-of-care respiratory test, which, according to Lumos, delivers results in around 10 minutes from a fingerstick blood sample** LDX falls 25.7% this year, as of last close  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4N3RM05I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU"],"gpt_icon":0},{"id":"2533056680","title":"Several Insiders Invested In Lumos Diagnostics Holdings Flagging Positive News","url":"https://stock-news.laohu8.com/highlight/detail?id=2533056680","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533056680?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:36","pubTimestamp":1746477384,"startTime":"0","endTime":"0","summary":"It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Lumos Diagnostics Holdings Limited's  case, it's fantastic news for shareholders.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.  We've discovered. Lumos Diagnostics Holdings Insider Transactions Over The Last Year. In the last twelve months, the biggest single purchase by an insider was when insider Peter Constable bought AU$78k worth of shares at a price of AU$0.031 per share. That means that an insider was happy to buy shares at above the current price of AU$0.028. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. It is generally more enco","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/several-insiders-invested-lumos-diagnostics-203624116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2531324895","title":"BUZZ-Australia's Lumos Diagnostics hits two-month high on upbeat Q3 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2531324895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531324895?lang=en_us&edition=fundamental","pubTime":"2025-04-29 11:15","pubTimestamp":1745896546,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Lumos Diagnostics hits two-month high on upbeat Q3 results** Shares of Lumos Diagnostics LDX.AX rise 11.5% to A$0.029, their highest level since February 28** Stock set for its strongest session since April 17, if current trends hold** Medical equipment supplier posts 21% increase in Q3 revenue compared to its previous quarter** About 6.1 mln shares change hands, 4.2x the 30-day average of 1.4 mln shares ** Stock down 17.1% YTD, including current session's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4N3R706R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2531135582","title":"BRIEF-Lumos Diagnostics Reports Revenue Of Us$3.5 Million For Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2531135582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531135582?lang=en_us&edition=fundamental","pubTime":"2025-04-29 09:23","pubTimestamp":1745889788,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Reports Revenue Of Us$3.5 Million For QuarterApril 29 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:REVENUE OF US$3.5 MILLION FOR QUARTERFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R62KD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU"],"gpt_icon":0},{"id":"2531295983","title":"Lumos Diagnostics Holdings Ltd - Revenue of US$3.5 Mln for Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2531295983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531295983?lang=en_us&edition=fundamental","pubTime":"2025-04-29 07:01","pubTimestamp":1745881284,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R62KD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2529513372","title":"Lumos Diagnostics Holdings Expands US Medicare Reimbursement Coverage for Diagnostic Test, Shares Jump 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529513372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529513372?lang=en_us&edition=fundamental","pubTime":"2025-04-23 10:35","pubTimestamp":1745375736,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  received confirmation of Medicare reimbursement coverage in the US from two additional Medicare administrative contractors, First Coast Service Options and Noridian Healthcare Solutions, according to a Wednedsay Australian bourse filing.The firm's FebriDx point-of-care diagnostic test will be included in the Medicare fee schedule of the contractors at at $41.38 per test retroactively from April 1.Its shares jumped 4% in recent trading on Wednesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2528753498","title":"Lumos Diagnostics to Receive Medicare Reimbursement for Test in Two US Regions; Shares Rise 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528753498","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528753498?lang=en_us&edition=fundamental","pubTime":"2025-04-17 13:38","pubTimestamp":1744868321,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  said it will start receiving Medicare reimbursement for its FebriDx rapid diagnostic test designed to distinguish bacterial from viral respiratory infections in two US regions, according to a Thursday filing with the Australian bourse.Effective this month, the test has been included in the Medicare fee schedule in the Palmetto and Novitas regions at a rate of $41.38 per test, the filing said.The test is reimbursable in both moderately complex and clinical laboratory improvement amendments waived settings, the company said.Shares of the company rose about 14% in recent Thursday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LDX.AU","RF","BK4211","BK7126"],"gpt_icon":0},{"id":"2517499140","title":"Lacklustre Performance Is Driving Lumos Diagnostics Holdings Limited's (ASX:LDX) 29% Price Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2517499140","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517499140?lang=en_us&edition=fundamental","pubTime":"2025-03-08 04:54","pubTimestamp":1741380884,"startTime":"0","endTime":"0","summary":"To the annoyance of some shareholders, Lumos Diagnostics Holdings Limited ( ASX:LDX ) shares are down a considerable...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/lacklustre-performance-is-driving-lumos-diagnostics-holdings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2516701935","title":"Lumos Diagnostics Holdings Agrees to Expand Scope of Work for Women's Health Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2516701935","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516701935?lang=en_us&edition=fundamental","pubTime":"2025-03-03 14:40","pubTimestamp":1740984034,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  and Hologic agreed to expand the scope of work for the new fetal fibronectin test, according to a Monday Australian bourse filing.The expanded scope of work relates to phase 3 of the development agreement, which focuses on delivery of the system prototype and will include the incorporation of additional hardware features into the proprietary reader technology.This is expected to generate additional fee revenue for Lumos of between $600,000 to $800,000.Phase 2 of the development agreement is expected to complete around April. The phase seeks to demonstrate that the assay can detect a biomarker.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2514381566","title":"BRIEF-Lumos Diagnostics Posts HY Loss Attributable $2.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381566","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514381566?lang=en_us&edition=fundamental","pubTime":"2025-02-27 09:29","pubTimestamp":1740619740,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Posts HY Loss Attributable $2.8 MlnFeb 27 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:HY LOSS ATTRIBUTABLE $2.8 MILLIONHY REVENUES FROM ORDINARY ACTIVITIES $6.3 MILLIONFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PH1SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2514898460","title":"Lumos Diagnostics -  Hy Loss Attributable $2.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898460?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:31","pubTimestamp":1740605507,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2507932730","title":"BRIEF-Lumos Diagnostics Logs Unaudited Revenue $2.9 Mln For Qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2507932730","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507932730?lang=en_us&edition=fundamental","pubTime":"2025-01-31 16:45","pubTimestamp":1738313105,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Logs Unaudited Revenue $2.9 Mln For QtrJan 31 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:UNAUDITED REVENUE OF US$2.9 MILLION FOR QUARTERFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OQ1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU"],"gpt_icon":0},{"id":"2507606409","title":"Lumos Diagnostics  - Unaudited Revenue of US$2.9 Mln for Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2507606409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507606409?lang=en_us&edition=fundamental","pubTime":"2025-01-31 06:02","pubTimestamp":1738274565,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ1LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2505933262","title":"Lumos Diagnostics Holdings Limited's (ASX:LDX) Share Price Boosted 31% But Its Business Prospects Need A Lift Too","url":"https://stock-news.laohu8.com/highlight/detail?id=2505933262","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505933262?lang=en_us&edition=fundamental","pubTime":"2025-01-21 04:01","pubTimestamp":1737403261,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings Limited ( ASX:LDX ) shareholders would be excited to see that the share price has had a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/lumos-diagnostics-holdings-limiteds-asxldx-share-price-boost","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LDX.AU","BK7126"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null},{"market":"AU","date":"2023-08-30","symbol":"LDX.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1693317600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[]}}